How health systems factors affect access to psychotropic medicines

In a cross-sectional analysis of WHO-AIMS data published in this week's PLoS Medicine, Ryan McBain of Harvard School of Public Health, Boston, USA and colleagues investigated the associations between health system components and access to psychotropic drugs in 63 low- and middle- income countries (LAMICs).

The authors' findings indicate that access to psychotropic medicines in LAMICs is related to key components within the mental health systems of these countries but that availability and are affected to different extents by these components.

The authors state: "Results suggest that strengthening specific mental health systems features might be an important way to facilitate access to psychotropic medicines, and results also underscore the differentially greater role of country development in promoting affordability."

More information: McBain R, Norton DJ, Morris J, Yasamy MT, Betancourt TS (2012) The Role of Health Systems Factors in Facilitating Access to Psychotropic Medicines: A Cross-Sectional Analysis of the WHO-AIMS in 63 Low- and Middle-Income Countries. PLoS Med 9(1): e1001166. doi:10.1371/journal.pmed.1001166

add to favorites email to friend print save as pdf

Related Stories

American kids most medicated

Sep 25, 2008

American children are approximately three times more likely to be prescribed psychotropic medication than children in Europe. A new study published today in BioMed Central's open access journal Child and Adolescent Psychiatry an ...

Danish children at risk from psychotropic medicines

Jun 22, 2010

Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions (ADRs) in children under 17 in Denmark. Researchers writing in the open access journal BMC Research Notes found that more than h ...

Recommended for you

User comments